Pneumoconiosis and Dust Exposure China Study
Part of Lungs & breathing clinical trials.
This study is building a long-term group of people with pneumoconiosis to better understand the disease and how dust exposure affects health. It does not involve any new treatments or medicines.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have been diagnosed with pneumoconiosis (a lung disease caused by breathing in dust).
- You must be able to share your complete work history, including jobs where you were exposed to dust.
- You cannot be currently taking part in any other clinical trial that tests a treatment or medicine.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 3 trial tests whether pirfenidone slows or improves lung damage in people with silicosis or coal worker’s pneumoconiosis. It looks at both effectiveness and side effects, and uses lung function tests and lung scans to track changes over time.
This study tests a modified traditional Chinese herbal formula (Qing-Zao-Jiu-Fei Decoction) to see if it helps people with pneumoconiosis (a chronic lung disease caused by dust exposure). The treatment aims to reduce symptoms and improve lung health.
This study follows people with COPD (chronic lung disease) over many years to better understand the condition. It may help doctors learn what factors predict worsening over time.
This study follows adults with asthma over about 2 years to learn more about asthma and how people do over time. If you qualify, you’ll be asked to join regular visits and follow the study plan.
This study is a registry that collects information from people in China who have progressive pulmonary fibrosis (PPF), a lung condition that gets worse over time. It aims to better understand the disease and help doctors improve care.
This study is following up with people who already took part in a large health survey in China. It looks at how multiple health conditions develop over time and why some people stay healthier than others.
Hear when a new Pneumoconiosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.